Corera Health

Redefining the Future of Cardiovascular Health.

Corsera Health is redefining the future of health by enabling earlier prediction of atherosclerotic cardiovascular disease (ASCVD) and developing a once-annual RNAi medicine to prevent cumulative damage to the cardiovascular system.

Corsera Health is combining decades of innovation in RNAi therapeutics, with world-leading expertise in cardiovascular disease prediction, efficient manufacturing and evidence generation, and disruptive commercialization. This approach has the potential to change the trajectory of cardiovascular disease, improving healthspan (living longer and healthier), reducing healthcare costs, and boosting human productivity.